Dimensional Fund Advisors LP Has $3.93 Million Holdings in SelectQuote, Inc. (NYSE:SLQT)

Dimensional Fund Advisors LP grew its position in SelectQuote, Inc. (NYSE:SLQT - Free Report) by 35.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,055,860 shares of the company's stock after purchasing an additional 275,593 shares during the quarter. Dimensional Fund Advisors LP owned about 0.62% of SelectQuote worth $3,929,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in SLQT. JPMorgan Chase & Co. raised its stake in SelectQuote by 36.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock worth $932,000 after purchasing an additional 115,865 shares in the last quarter. Barclays PLC raised its position in shares of SelectQuote by 166.8% in the third quarter. Barclays PLC now owns 198,357 shares of the company's stock valued at $430,000 after buying an additional 124,005 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock valued at $340,000 after buying an additional 8,660 shares during the period. Oppenheimer & Co. Inc. bought a new stake in shares of SelectQuote in the fourth quarter valued at approximately $47,000. Finally, Wells Fargo & Company MN grew its position in SelectQuote by 13.4% during the fourth quarter. Wells Fargo & Company MN now owns 154,945 shares of the company's stock worth $576,000 after buying an additional 18,261 shares in the last quarter. Institutional investors and hedge funds own 34.59% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Noble Financial raised SelectQuote to a "strong-buy" rating in a report on Wednesday, February 12th.

Insider Buying and Selling at SelectQuote

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total value of $272,000.00. Following the completion of the transaction, the insider now owns 1,166 shares of the company's stock, valued at approximately $6,343.04. This represents a 97.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.40% of the company's stock.

SelectQuote Price Performance

SLQT traded down $0.03 on Friday, hitting $2.30. 1,056,538 shares of the stock were exchanged, compared to its average volume of 1,413,955. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36. SelectQuote, Inc. has a 12 month low of $1.62 and a 12 month high of $6.86. The firm has a market capitalization of $395.07 million, a price-to-earnings ratio of -25.50 and a beta of 1.26. The business has a 50-day moving average of $3.19 and a two-hundred day moving average of $3.49.

SelectQuote (NYSE:SLQT - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $408.16 million for the quarter, compared to analyst estimates of $412.83 million. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. Sell-side analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current fiscal year.

SelectQuote Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.